Bar Harbor, Maine
United States
175
2026-03-26
81
2025-09-09
These are the the leading inventors for applications assigned to THE JACKSON LABORATORY:
THE JACKSON LABORATORY based in Bar Harbor, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
HUMANIZED IMMUNODEFICIENT MOUSE MODELS
#2 | 2026-03-05COMPOSITIONS AND METHODS FOR TREATING MENINGIOMA
#3 | 2026-03-05METHODS AND COMPOSITIONS FOR INHIBITING CLONAL HEMATOPOIESIS
#4 | 2026-02-05METHODS AND MODELS FOR ASSESSING EFFICACY OF IMMUNOTHERAPIES
#5 | 2025-12-04MOUSE MODELS OF CYTOKINE RELEASE SYNDROME
#6 | 2025-12-04METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH COMPRISING GDNF ADMINISTRATION
#7 | 2025-11-20TRANSGENIC MOUSE MODELS SUPPORTING INNATE IMMUNE FUNCTION
#8 | 2025-11-20WILD-DERIVED MOUSE MODELS OF ALZHEIMER’S DISEASE
#9 | 2025-10-30IMPLANTABLE DATA LOGGER ANCHORING DEVICES
#10 | 2025-10-23TREATMENTS FOR CHARCOT-MARIE-TOOTH DISEASE
#11 | 2025-10-09TRANSGENIC MOUSE MODELS OF HUMAN ADAPTIVE AND INNATE IMMUNITY AND METHODS OF USE
#12 | 2025-09-09 ✅ Patent 12,409,237 granted on 2025-09-09Methods and models for assessing efficacy of immunotherapies
#13 | 2025-07-17GENETICALLY MODIFIED MOUSE MODELS OF ALZHEIMER’S DISEASE
#14 | 2025-07-03COMBINATION IMMUNE CHECKPOINT INHIBITOR THERAPIES
#15 | 2025-07-03IMMUNODEFICIENT FCGR1 KNOCKOUT MOUSE MODELS
#16 | 2025-05-29METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH COMPRISING GDNF ADMINISTRATION
#17 | 2025-05-22HUMANIZED MOUSE MODELS FOR ASSESSING IMMUNE CELL THERAPY
#18 | 2025-04-17HUMANIZED MOUSE MODEL OF FIBROSIS
#19 | 2025-02-20HUMANIZED MOUSE MODELS
#20 | 2025-02-13HUMANIZED MOUSE MODELS OF THE FCRN RECYCLING PATHWAY
#21 | 2025-02-06METHODS AND COMPOSITIONS RELATING TO HUMANIZED STATHMIN2 MOUSE MODEL WITH DISRUPTED TDP-43 BINDING SITES
#22 | 2025-01-16METHODS AND APPARATUS FOR IDENTIFYING ALTERNATIVE SPLICING EVENTS
#23 | 2025-01-16METHODS AND COMPOSITIONS FOR SUPPRESSING AGING-ASSOCIATED CLONAL HEMATOPOIESIS
#24 | 2024-12-03 ✅ Patent 12,156,517 granted on 2024-12-03Humanized mouse models of the FcRn recycling pathway
#25 | 2024-11-21ANTI-NGLY-1 ANTIBODIES AND METHODS OF USE
#26 | 2024-09-26GENETICALLY MODIFIED MOUSE EXPRESSING HUMAN APOE4 AND MOUSE TREM2 P.R47H AND METHODS OF USE THEREOF
#27 | 2024-08-29 ✅ Patent 12,510,548 granted on 2025-12-30METHOD OF DETERMINING TOXICITY OF AN IMMUNOMODULATORY DRUG FOR USE IN HUMANS
#28 | 2024-08-01GENE MUTATIONS ASSOCIATED WITH TANDEM DUPLICATOR PHENOTYPE
#29 | 2024-06-06 ✅ Patent 12,357,674 granted on 2025-07-15METHODS FOR PROMOTING WOUND HEALING AND HAIR GROWTH
#30 | 2024-05-02MULTIPLEX RNA TARGETING
#31 | 2024-04-25TARGETED DNA DEMETHYLATION AND METHYLATION
#32 | 2024-03-28TRPC3 AS A THERAPEUTIC TARGET FOR ALZHEIMER’S DISEASE
#33 | 2024-02-29PROGNOSTIC METHODS FOR PLATINUM-BASED CHEMOTHERAPEUTICS
#34 | 2024-02-29A GENETICALLY MODIFIED IMMUNODEFICIENT MOUSE EXPRESSING HUMAN OR HUMANIZED APP AND MUTATED HUMAN PSEN1
#35 | 2024-02-08INFECTIOUS DISEASE MOUSE MODELS
#36 | 2024-01-11ANTIMICROBIAL BIOSENSORS
#37 | 2023-12-28 ✅ Patent 12,347,112 granted on 2025-07-01Long-Term and Continuous Animal Behavioral Monitoring
#38 | 2023-12-28 ✅ Patent 11,959,926 granted on 2024-04-16Method of determining toxicity of an immunomodulatory drug for use in humans preliminary class
#39 | 2023-12-28THERAPEUTICS TARGETING TRANSFORMING GROWTH FACTOR BETA FAMILY SIGNALING
#40 | 2023-12-21MODIFIED ANTISENSE OLIGONUCLEOTIDES TARGETING SPLICING FACTORS
#41 | 2023-12-07MURINE-MHC-DEFICIENT HLA-TRANSGENIC NOD-MOUSE MODELS FOR T1D THERAPY DEVELOPMENT
#42 | 2023-11-30 ✅ Patent 12,274,879 granted on 2025-04-15Optical pressure treatment through electrical stimulation
#43 | 2023-11-23BREAST CANCER SPLICE VARIANTS
#44 | 2023-11-02SARS-COV-2 THERAPIES
#45 | 2023-10-26TRANSGENIC MOUSE MODELS SUPPORTING HUMAN INNATE IMMUNE FUNCTION
#46 | 2023-10-05PRESSURE SENSORS FOR SMALL-SCALE APPLICATIONS AND RELATED METHODS
#47 | 2023-09-21SYSTEMS AND METHODS FOR GENE VARIANT GROUPING AND VISUALIZATION
#48 | 2023-09-14SINGLE GENERATION TARGETED GENE INTEGRATION
#49 | 2023-08-31TRANSGENIC MOUSE MODEL EXPRESSING HUMAN HLA-A201 RESTRICTION GENE
#50 | 2023-08-17HUMANIZED MOUSE MODELS FOR SARS-COV-2 INFECTION
#51 | 2023-04-13ACTIVATION OF LYTIC GENES IN CANCER CELLS
#52 | 2023-03-30REGULATORY ELEMENTS IN THE GENOME
#53 | 2023-03-23BACTERIAL ADMIXTURES
#54 | 2023-03-09 ✅ Patent 12,428,638 granted on 2025-09-30THREE-COMPONENT CRISPR/CAS COMPLEX SYSTEM AND USES THEREOF
#55 | 2023-02-23 ✅ Patent 12,551,481 granted on 2026-02-17MOLECULAR TARGETS FOR ADDICTION
#56 | 2023-02-09METHODS AND SYSTEMS FOR DIAGNOSIS OF MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS) FROM IMMUNE MARKERS
#57 | 2023-01-19METHOD OF SELECTING A TREATMENT FOR AN MS PATIENT
#58 | 2022-12-08TREATMENTS FOR CHARCOT-MARIE-TOOTH DISEASE
#59 | 2022-11-24HIGH FREQUENCY TARGETED ANIMAL TRANSGENESIS
#60 | 2022-11-10 ✅ Patent 12,336,986 granted on 2025-06-24TREATMENT AND PREVENTION OF OCULAR NEURODEGENERATIVE DISORDER
#61 | 2022-10-20LIVE CELL IMAGING OF NON-REPETITIVE GENOMIC LOCI
#62 | 2022-08-25 ✅ Patent 12,380,555 granted on 2025-08-05CONVOLUTIONAL NEURAL NETWORKS FOR CLASSIFICATION OF CANCER HISTOLOGICAL IMAGES
#63 | 2022-08-11 ✅ Patent 11,798,167 granted on 2023-10-24Long-term and continuous animal behavioral monitoring
#64 | 2022-08-04ANTIBODIES AND FC FUSION PROTEIN MODIFICATIONS WITH ENHANCED PERSISTENCE OR PHARMACOKINETIC STABILITY IN VIVO AND METHODS OF USE THEREOF
#65 | 2022-07-14EXTRACHROMOSOMAL DNA IDENTIFICATION AND METHODS OF USE
#66 | 2022-07-07 ✅ Patent 12,196,744 granted on 2025-01-14Humanized mouse models for assessing immune cell therapy
#67 | 2022-06-30COMPOSITIONS AND METHODS OF TREATING ASTHMA
#68 | 2022-05-05 ✅ Patent 12,378,574 granted on 2025-08-05TRANSGENIC MOUSE MODELS SUPPORTING INNATE IMMUNE FUNCTION
#69 | 2022-04-28 ✅ Patent 12,595,490 granted on 2026-04-07NON-HLA MATCHED HUMANIZED NSG MOUSE MODEL WITH PATIENT-DERIVED XENOGRAFT
#70 | 2022-04-28 ✅ Patent 12,577,584 granted on 2026-03-17NON-HLA MATCHED HUMANIZED NSG MOUSE MODEL WITH PATIENT-DERIVED XENOGRAFT
#71 | 2022-03-03 ✅ Patent 11,890,322 granted on 2024-02-06Methods for promoting wound healing and hair growth comprising GDNF administration
#72 | 2022-02-24METHOD AND APPARATUS FOR DETECTING COPY NUMBER VARIATIONS IN A GENOME
#73 | 2022-01-06METHOD OF DETERMINING TOXICITY OF AN IMMUNOMODULATORY DRUG FOR USE IN HUMANS
#74 | 2021-12-23 ✅ Patent 12,377,073 granted on 2025-08-05TREATMENTS FOR CHARCOT-MARIE-TOOTH DISEASE
#75 | 2021-12-16ARTIFICIAL RNA-GUIDED SPLICING FACTORS
#76 | 2021-11-11 ✅ Patent 11,730,961 granted on 2023-08-22Optical pressure treatment through electrical stimulation
#77 | 2021-11-04METHODS AND APPARATUS FOR PHENOTYPE-DRIVEN CLINICAL GENOMICS USING A LIKELIHOOD RATIO PARADIGM
#78 | 2021-10-21GASTRIC CANCER TREATMENTS
#79 | 2021-10-21DLGAP2 AS A THERAPEUTIC TARGET FOR AND ALZHEIMER'S DISEASE AND AGE-RELATED COGNITIVE DECLINE
#80 | 2021-10-14METHODS FOR PREVENTING AND TREATING TYPE II DIABETES
#81 | 2021-10-14 ✅ Patent 12,435,316 granted on 2025-10-07THREE DIMENSIONAL HUMAN BRAIN TUMOR MODELS
#82 | 2021-08-19 ✅ Patent 11,674,187 granted on 2023-06-13Breast cancer splice variants
#83 | 2021-07-29 ✅ Patent 12,051,496 granted on 2024-07-30Methods and apparatus for identifying alternative splicing events
#84 | 2021-07-01GENETICALLY MODIFIED MOUSE MODELS OF ALZHEIMER'S DISEASE
#85 | 2021-06-24SEQUENCE DETECTION SYSTEMS
#86 | 2021-05-13 ✅ Patent 12,054,558 granted on 2024-08-06Anti-NGly-1 antibodies and methods of use
#87 | 2021-05-06 ✅ Patent 11,959,925 granted on 2024-04-16Method of determining toxicity of an immunomodulatory drug for use in humans
#88 | 2021-03-25COMBINATION THERAPIES FOR TREATING CANCERS
#89 | 2021-03-18CLEAVAGE-RESISTANT DONOR NUCLEIC ACIDS AND METHODS OF USE
#90 | 2021-03-04 ✅ Patent 12,612,657 granted on 2026-04-28EXTRACHROMOSOMAL DNA LABELING
#91 | 2020-11-26 ✅ Patent 12,270,042 granted on 2025-04-08Methods for preventing and treating type II diabetes
#92 | 2020-11-19 ✅ Patent 11,785,923 granted on 2023-10-17Genetically modified non-human animals and methods relating to complement dependent cytotoxicity
#93 | 2020-10-29 ✅ Patent 11,330,804 granted on 2022-05-17Long-term and continuous animal behavioral monitoring
#94 | 2020-08-20TRANSGENIC SELECTION METHODS AND COMPOSITIONS
#95 | 2020-07-30 ✅ Patent 11,136,377 granted on 2021-10-05Antibodies and Fc fusion protein modifications with enhanced persistence or pharmacokinetic stability in vivo and methods of use thereof
#96 | 2020-07-30PRESSURE SENSORS FOR SMALL-SCALE APPLICATIONS AND RELATED METHODS
#97 | 2020-07-30IMMUNODEFICIENT MICE EXPRESSING HUMAN INTERLEUKIN 15
#98 | 2020-06-25 ✅ Patent 11,369,695 granted on 2022-06-28Fat droplets in retina and optic nerve as a diagnostic marker for neurodegeneration and glaucoma in humans
#99 | 2020-05-21 ✅ Patent 11,723,347 granted on 2023-08-15TRPC3 as a therapeutic target for alzheimer's disease
#100 | 2020-04-23SINGLE NUCLEUS AND SINGLE MOLECULE CHROMATIN INTERACTION ASSAYS
Also check out The Jackson Laboratory's (Bar Harbor, United States) applicant profile with 105 patent applications submitted.
22887 ⎘